CN101095927A - Medicine for treating rheumatism or postpartum rheumatism - Google Patents

Medicine for treating rheumatism or postpartum rheumatism Download PDF

Info

Publication number
CN101095927A
CN101095927A CNA2007100120145A CN200710012014A CN101095927A CN 101095927 A CN101095927 A CN 101095927A CN A2007100120145 A CNA2007100120145 A CN A2007100120145A CN 200710012014 A CN200710012014 A CN 200710012014A CN 101095927 A CN101095927 A CN 101095927A
Authority
CN
China
Prior art keywords
parts
rheumatism
medicine
rhizoma
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007100120145A
Other languages
Chinese (zh)
Inventor
张忠民
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNA2007100120145A priority Critical patent/CN101095927A/en
Publication of CN101095927A publication Critical patent/CN101095927A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicament for treating rheumatism which comprises the following raw materials (by weight portion): sweet osmanthus flower 40-60 parts, herbaceous peony 30-50 parts, dried ginger 50-70 parts, Chinese ephedra 30-50 parts, white atractylodes rhizome 50-70 parts, Chinese mugwort leaf 40-60 parts, wind-weed rhizome 40-60 parts, monkshood 20-40 parts, hemp seeds 40-60 parts, licorice 20-30 parts.

Description

A kind of medicine for the treatment of rheumatism or postpartum rheumatism
Technical field
The present invention relates to a kind of medicine for the treatment of rheumatism or postpartum rheumatism, its trade name is the clean capsule prescription of row sesame hall three wind.
Background technology
About 400,000,000 people of whole world rheumatisant are class illness the hugest in the medical domain, in China, and rheumatic arthritis, patient with rheumatoid arthritis accounts for 18% of population.Its sickness rate can reach 20%, and 8,000 ten thousand severe cases are wherein arranged.Investigation shows that 2000 so far, and annual rheumatisant's medication amount of money has all surpassed 200 hundred million! China has at least 200,000,000 people tormented by this pertinacious disease, and 80% is effectively treated, and controls repeatly and does not heal, and sb.'s illness took a turn for the worse, is forced to the edge of paralysis.Rheumatism is commonly called as not dead cancer, at every moment urges residual human beings'health, obstinate, and outbreak makes patient's pain repeatedly, makes the doctor have a headache, and according to relevant expert's statistics, the whole nation has 40% rheumatic sufferers paralysis occur every year.Therefore treat rheumatism and be in an emergency in the whole nation, very urgent.
Summary of the invention
Up to now, also do not find the report of any relevant pharmaceutical composition of the present invention.The inventor, proves and adopts Drug therapy of the present invention according to a large amount of clinical practices through research for many years, the cure rate height, and relapse rate is low.
The purpose of this invention is to provide a kind of good effect, the medicine of the treatment rheumatism or postpartum rheumatism that cure rate is high.
Medicine components consumption of the present invention is to draw in development test for many years and clinical trial summary through the inventor, and the each component consumption has curative effect preferably in following weight portion scope:
A kind of medicine for the treatment of rheumatism or postpartum rheumatism, it is made up of following bulk drugs: 40~60 parts of Ramulus Cinnamomi, 30~50 parts of Radix Paeoniaes, 50~70 parts of Rhizoma Zingiberiss, 30~50 parts in Herba Ephedrae, 50~70 parts of the Rhizoma Atractylodis Macrocephalaes, 40~60 parts of Folium Artemisiae Argyis, 40~60 parts of the Rhizoma Anemarrhenaes, 20~40 parts of Radix Aconiti Lateralis Preparatas, 40~60 parts of Fructus Cannabiss, 20~30 parts in Radix Glycyrrhizae.
The described medicine wherein best proportioning of crude drug is: 50 parts of Ramulus Cinnamomi, 40 parts of Radix Paeoniaes, 60 parts of Rhizoma Zingiberiss, 40 parts in Herba Ephedrae, 60 parts of the Rhizoma Atractylodis Macrocephalaes, 50 parts of Folium Artemisiae Argyis, 50 parts of the Rhizoma Anemarrhenaes, 30 parts of Radix Aconiti Lateralis Preparatas, 50 parts of Fructus Cannabiss, 25 parts in Radix Glycyrrhizae.
In the above-mentioned raw materials medicine: Ramulus Cinnamomi, hot, sweet, temperature. GUIXIN, lung, bladder have the effect of relieving the exterior syndrome by diaphoresis, antalgic, supporing yang activating QI; Radix Paeoniae, cold nature, bitter in the mouth has analgesia effect such as analgesic; Rhizoma Zingiberis, function cures mainly: warming spleen and stomach for dispelling cold, recuperating depleted YANG is promoted blood circulation, the dampness expectorant.Be used for coldness and pain in the epigastrium, vomiting is had loose bowels, cold extremities faint pulse, phlegm retention cough with asthma; Herba Ephedrae, warm in nature, acrid in the mouth, little hardship have the diaphoresis cold expelling, depressed lung-energy dispersing, the effect of inducing diuresis to remove edema; The Rhizoma Atractylodis Macrocephalae, warm in nature, sweet-bitter flavor has invigorating the spleen and benefiting QI, the promoting diuresis to clear away damp pathogen effect; Folium Artemisiae Argyi, toil, temperature is gone into spleen, liver, kidney channel, and reasonable QI and blood is by the effect of cold-damp; The Rhizoma Anemarrhenae, nature and flavor are cold in nature, and bitter in the mouth, sweet has clearing away heat-fire, the effect of promoting the production of body fluid and moisturizing; Radix Aconiti Lateralis Preparata, hot, sweet, big heat, poisonous, GUIXIN, kidney, spleen channel have recuperating depleted YANG and rescuing the patient from collapse, and it is supporing yang to mend fire, the effect of dispersing cold for relieving pain; Fructus Cannabis, property is flat, and sweet in the mouth has the effect of moisturizing the laxation relieving constipation; Radix Glycyrrhizae, property is flat, and sweet in the mouth has detoxifcation, eliminates the phlegm, pain relieving, spasmolytic be so that pharmacological action such as anticancer.
Medicine of the present invention can adopt the conventional method of Chinese medicine preparation to be prepared into any conventional oral preparations, for example these crude drug pulverize mix homogeneously can be made powder then, or pill or capsule.
Compared with prior art, the present invention has the following advantages and remarkable result: the present invention cures mainly diseases such as rheumatism, rheumatoid, puerperal exposure to wind, rheumatic arthritis and noxious dampness measles, and cure rate can reach 98%, and effective percentage reaches 100%.
The specific embodiment
[clinical observation]
1, physical data
Accept out-patient's totally 600 examples for medical treatment, wherein male 150 examples, women 450 examples, men and women's ratio is 1: 3.Age 15-30 year 110 examples, 31-65 year 480 examples.
2, diagnostic criteria: tcm syndrome differentiation and typing, doctor trained in Western medicine check diagnosis.
3, Therapeutic Method: once a day, each 10-15 grain, every 1.5g.
4, efficacy assessment standard
Cure: transference cure, drug withdrawal is not recurred March.
Produce effects: transference cure.
Effectively: sx.
Invalid: symptom does not have change.
The therapeutic outcome statistics
Week treatment time Invalid Effectively Produce effects Cure Total effective rate
The example number Inefficiency The example number Effective percentage The example number Obvious effective rate The example number Cure rate
7 all 8 weeks of 6 weeks in 5 weeks in 4 weeks in 3 weeks in 2 weeks in 1 week 282 180 120 90 72 48 12 0 47% 30% 20% 15% 12% 8% 2% 0 270 150 60 30 18 12% 6 6 45% 25% 10% 5% 3% 2% 1% 1% 48 240 300 150 180 60 12 6 8% 40% 50% 25% 20% 10% 2% 1% 0 30 120 300 390 480 570 588 0 5% 20% 50% 65% 80% 95% 98% 53% 70% 80% 85% 88% 92% 98% 100%
In a word, in the treatment in 8 weeks, with Drug therapy patient's 600 examples of the present invention, the result cures 588 examples, produce effects 6 examples, effective 6 examples, invalid 0 example, cure rate 98%, obvious effective rate 1%, total effective rate 100%.
Come further to set forth the preparation method of medicine of the present invention by the following examples.
Embodiment 1:
A kind of medicine for the treatment of rheumatism or postpartum rheumatism, it is made up of following bulk drugs: 40 parts of Ramulus Cinnamomi, 30 parts of Radix Paeoniaes, 50 parts of Rhizoma Zingiberiss, 30 parts in Herba Ephedrae, 50 parts of the Rhizoma Atractylodis Macrocephalaes, 40 parts of Folium Artemisiae Argyis, 40 parts of the Rhizoma Anemarrhenaes, 20 parts of Radix Aconiti Lateralis Preparatas, 40 parts of Fructus Cannabiss, 20 parts in Radix Glycyrrhizae.
Adopt the conventional method of Chinese medicine preparation to make powder.
Embodiment 2:
A kind of medicine for the treatment of rheumatism or postpartum rheumatism, it is made up of following bulk drugs: 50 parts of Ramulus Cinnamomi, 40 parts of Radix Paeoniaes, 60 parts of Rhizoma Zingiberiss, 40 parts in Herba Ephedrae, 60 parts of the Rhizoma Atractylodis Macrocephalaes, 50 parts of Folium Artemisiae Argyis, 50 parts of the Rhizoma Anemarrhenaes, 30 parts of Radix Aconiti Lateralis Preparatas, 50 parts of Fructus Cannabiss, 25 parts in Radix Glycyrrhizae.
Adopt the conventional method of Chinese medicine preparation to make pill.
Embodiment 3:
A kind of medicine for the treatment of rheumatism or postpartum rheumatism, it is made up of following bulk drugs: 60 parts of Ramulus Cinnamomi, 50 parts of Radix Paeoniaes, 70 parts of Rhizoma Zingiberiss, 50 parts in Herba Ephedrae, 70 parts of the Rhizoma Atractylodis Macrocephalaes, 60 parts of Folium Artemisiae Argyis, 60 parts of the Rhizoma Anemarrhenaes, 40 parts of Radix Aconiti Lateralis Preparatas, 60 parts of Fructus Cannabiss, 30 parts in Radix Glycyrrhizae.
Adopt the conventional method of Chinese medicine preparation to make capsule.

Claims (2)

1, a kind of medicine for the treatment of rheumatism or postpartum rheumatism, it is characterized in that it is made up of following bulk drugs: 40~60 parts of Ramulus Cinnamomi, 30~50 parts of Radix Paeoniaes, 50~70 parts of Rhizoma Zingiberiss, 30~50 parts in Herba Ephedrae, 50~70 parts of the Rhizoma Atractylodis Macrocephalaes, 40~60 parts of Folium Artemisiae Argyis, 40~60 parts of the Rhizoma Anemarrhenaes, 20~40 parts of Radix Aconiti Lateralis Preparatas, 40~60 parts of Fructus Cannabiss, 20~30 parts in Radix Glycyrrhizae.
2, a kind of medicine for the treatment of rheumatism or postpartum rheumatism according to claim 1, it is characterized in that the described medicine wherein best proportioning of crude drug is: 50 parts of Ramulus Cinnamomi, 40 parts of Radix Paeoniaes, 60 parts of Rhizoma Zingiberiss, 40 parts in Herba Ephedrae, 60 parts of the Rhizoma Atractylodis Macrocephalaes, 50 parts of Folium Artemisiae Argyis, 50 parts of the Rhizoma Anemarrhenaes, 30 parts of Radix Aconiti Lateralis Preparatas, 50 parts of Fructus Cannabiss, 25 parts in Radix Glycyrrhizae.
CNA2007100120145A 2007-07-10 2007-07-10 Medicine for treating rheumatism or postpartum rheumatism Pending CN101095927A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2007100120145A CN101095927A (en) 2007-07-10 2007-07-10 Medicine for treating rheumatism or postpartum rheumatism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2007100120145A CN101095927A (en) 2007-07-10 2007-07-10 Medicine for treating rheumatism or postpartum rheumatism

Publications (1)

Publication Number Publication Date
CN101095927A true CN101095927A (en) 2008-01-02

Family

ID=39010150

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007100120145A Pending CN101095927A (en) 2007-07-10 2007-07-10 Medicine for treating rheumatism or postpartum rheumatism

Country Status (1)

Country Link
CN (1) CN101095927A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103394058A (en) * 2013-07-29 2013-11-20 肖变化 Medicament for treating postpartum disease and preparation method thereof
CN104027732A (en) * 2014-05-23 2014-09-10 烟台瑞智生物医药科技有限公司 Traditional Chinese medicine (TCM) for treating postpartum pain of body induced by wind-cold symptom

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103394058A (en) * 2013-07-29 2013-11-20 肖变化 Medicament for treating postpartum disease and preparation method thereof
CN103394058B (en) * 2013-07-29 2015-07-01 肖变化 Medicament for treating postpartum disease and preparation method thereof
CN104027732A (en) * 2014-05-23 2014-09-10 烟台瑞智生物医药科技有限公司 Traditional Chinese medicine (TCM) for treating postpartum pain of body induced by wind-cold symptom

Similar Documents

Publication Publication Date Title
CN101524524B (en) Drug for treating severe cold and preparation method thereof
CN101797347B (en) Traditional Chinese medicinal composition for treating gastrointestinal tract and preparation thereof
CN104173937A (en) Traditional Chinese medicine composition for dispersing stagnated liver qi for promoting bile flow and applications thereof
CN100460008C (en) Chinese medicine composition for treating cancer
CN102078462A (en) Asthma relieving medicament
CN104189759A (en) Traditional Chinese medicine composition for treating cholelithiasis
CN103784804A (en) Pharmaceutical composition for treating benign prostatic hyperplasia
CN103405719A (en) Medicament for treatment of depression
CN101095927A (en) Medicine for treating rheumatism or postpartum rheumatism
CN105879000A (en) Pharmaceutic preparation for treating tonsillitis and application thereof
CN105641419A (en) Traditional Chinese medicine composition for treating Yin deficiency type cough caused by lung cancer
CN104225197A (en) Traditional Chinese medicine for treating tinnitus cerebri caused by syndrome of qi depression transforming into fire
CN102366606B (en) Atomized asthma relieving liquid and manufacturing method thereof
CN103394064A (en) Traditional Chinese medicine composition used for treating slight cold
CN103446425A (en) Herbal bagged tea bag for treating chronic pharyngitis
CN101983676A (en) Medicament for treating gynecological blood stasis and qi stagnation
CN106177774A (en) A kind of medicine treating pelvic inflammatory disease
CN105816847A (en) Traditional Chinese medicine composition for treating rhinitis
CN104288484A (en) Medicament for treating bronchitis and asthma
CN104524399A (en) Traditional Chinese medicine composition treating bronchial asthma
CN104147523A (en) Traditional Chinese medicine preparation for treating cholecystitis
CN103536836A (en) Medicine for reinforcing spleen to promote digestion
CN104740459A (en) Traditional Chinese medicine composition for treating cough
CN103372192A (en) Medicament for treating bronchial asthma
CN102688354A (en) Traditional Chinese medicine decoction of schizonepeta for treating cough and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20080102